PRELID1 and VDAC3 Coordinate a Senescence‐Like State in Germinal Center B Cells to Promote IL‐7–Driven Antitumor Immunity in Colorectal Cancer
Advanced Science · 2026
DOI: 10.1002/advs.202521951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuhan Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Nanfang Hospital, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Interleukin-7, Germinal Center, Mitochondrial Membrane Transport Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Colorectal cancer (CRC) is characterized by an immune‐suppressive microenvironment that facilitates to tumor progression and immunotherapy resistance. Emerging evidence indicates that tumor‐infiltrating B cell subsets play dual roles in modulating antitumor immunity. However, the mechanisms underlying their regulatory functions remain poorly understood. In this study, we constructed single‐cell transcriptomic analyses and a Bgc adoptive transfer model in B cell‐deficient mice, performing multifaceted validation to confirm that targeting the PRELID1–VDAC3–IL‐7 axis in senescence‐like germinal center B cells enhances sensitivity to anti‐PD‐L1 immunotherapy. Mechanistically, we identify a senescence‐like state in germinal center B cells (Bgc) that enhances antitumor immunity in CRC by promoting Interleukin‐7 (IL‐7) secretion and alleviating CD8 + T cell exhaustion. Specifically, this senescence‐like state is driven by PRELID1 and VDAC3 through their cooperative regulation of mitochondria‐lysosome interactions in Bgc cells, which enhances IL‐7 secretion and promotes functional crosstalk with CD8 + T cells to sustain antitumor immunity. In summary, our findings support a combinatorial strategy integrating targeting of the PRELID1–VDAC3–IL‐7 axis in senescence‐like Bgc cells with anti‐PD‐L1 immunotherapy for colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Nanfang Hospital, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China.
- Guangdong Province Key Laboratory of Molecular Tumor Pathology, Guangzhou, Guangdong, China.
- School of Computer Science, Guangdong Polytechnic Normal University, Guangzhou, China.
- School of Computer Science, University of Manchester, Manchester, UK.
- Department of Pathology, The Tenth Affiliated Hospital (Dongguan People's Hospital), Southern Medical University, Dongguan, China.
- Dongguan Clinical Pathology Diagnosis Center, Dongguan, China.
ORCID-Profile: Jun Zhou
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Liao, Y., Xu, H., Zhuo, X., Hu, S., Huang, L., Hao, Z., Chen, J., Wang, Y., & Zhou, J. (2026). PRELID1 and VDAC3 Coordinate a Senescence‐Like State in Germinal Center B Cells to Promote IL‐7–Driven Antitumor Immunity in Colorectal Cancer. Advanced Science. https://doi.org/10.1002/advs.202521951
Vancouver
Liao Y, Xu H, Zhuo X, Hu S, Huang L, Hao Z, et al. PRELID1 and VDAC3 Coordinate a Senescence‐Like State in Germinal Center B Cells to Promote IL‐7–Driven Antitumor Immunity in Colorectal Cancer. Advanced Science. 2026. doi:10.1002/advs.202521951
BibTeX
@article{Liao2026,
author = {Liao, Yuhan and Xu, Huimeng and Zhuo, Xinghua and Hu, Shupeng and Huang, Lanhui and Hao, Zhe and Chen, Jianxiong and Wang, Yulu and Zhou, Jun},
title = {PRELID1 and VDAC3 Coordinate a Senescence‐Like State in Germinal Center B Cells to Promote IL‐7–Driven Antitumor Immunity in Colorectal Cancer},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202521951}
}
EUVIMED